Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trialHiddo J.L. Heerspink, Chris Vercammen, Dalane W. Kitzman et al.|The Lancet|2019Cited by 609
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)Timothy M. E. Davis, Rury R. Holman, Alex Wright et al.|Diabetologia|2005Cited by 116
Autoantibodies to the islet cell antigen SOX‐13 are associated with duration but not type of diabetesTimothy M. E. Davis, Rury R. Holman, Z Mehta et al.|Diabetic Medicine|2003Cited by 10